Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis SC Ling, M Polymenidou, DW Cleveland Neuron 79 (3), 416-438, 2013 | 1859 | 2013 |
Protein phase separation: a new phase in cell biology S Boeynaems, S Alberti, NL Fawzi, T Mittag, M Polymenidou, F Rousseau, ... Trends in cell biology 28 (6), 420-435, 2018 | 1771 | 2018 |
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43 M Polymenidou, C Lagier-Tourenne, KR Hutt, SC Huelga, J Moran, ... Nature neuroscience 14 (4), 459-468, 2011 | 1426 | 2011 |
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond H Ilieva, M Polymenidou, DW Cleveland Journal of Cell Biology 187 (6), 761-772, 2009 | 1223 | 2009 |
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration C Lagier-Tourenne, M Polymenidou, DW Cleveland Human molecular genetics 19 (R1), R46-R64, 2010 | 1202 | 2010 |
Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs C Lagier-Tourenne, M Polymenidou, KR Hutt, AQ Vu, M Baughn, ... Nature neuroscience 15 (11), 1488-1497, 2012 | 847 | 2012 |
Mammalian prion biology: one century of evolving concepts A Aguzzi, M Polymenidou Cell 116 (2), 313-327, 2004 | 769 | 2004 |
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration C Lagier-Tourenne, M Baughn, F Rigo, S Sun, P Liu, HR Li, J Jiang, ... Proceedings of the National Academy of Sciences 110 (47), E4530-E4539, 2013 | 685 | 2013 |
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration M Heikenwalder, M Polymenidou, T Junt, C Sigurdson, H Wagner, S Akira, ... Nature medicine 10 (2), 187-192, 2004 | 548 | 2004 |
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43 ES Arnold, SC Ling, SC Huelga, C Lagier-Tourenne, M Polymenidou, ... Proceedings of the National Academy of Sciences 110 (8), E736-E745, 2013 | 520 | 2013 |
The seeds of neurodegeneration: prion-like spreading in ALS M Polymenidou, DW Cleveland Cell 147 (3), 498-508, 2011 | 442 | 2011 |
Insights into prion strains and neurotoxicity A Aguzzi, M Heikenwalder, M Polymenidou Nature reviews Molecular cell biology 8 (7), 552-561, 2007 | 429 | 2007 |
Prion strain discrimination using luminescent conjugated polymers CJ Sigurdson, KPR Nilsson, S Hornemann, G Manco, M Polymenidou, ... Nature methods 4 (12), 1023-1030, 2007 | 322 | 2007 |
Phase separation and neurodegenerative diseases: a disturbance in the force A Zbinden, M Pérez-Berlanga, P De Rossi, M Polymenidou Developmental cell 55 (1), 45-68, 2020 | 309 | 2020 |
Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation T Afroz, EM Hock, P Ernst, C Foglieni, M Jambeau, LAB Gilhespy, ... Nature communications 8 (1), 45, 2017 | 294 | 2017 |
Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease M Polymenidou, K Stoeck, M Glatzel, M Vey, A Bellon, A Aguzzi The Lancet Neurology 4 (12), 805-814, 2005 | 250 | 2005 |
Prion-like spread of protein aggregates in neurodegeneration M Polymenidou, DW Cleveland Journal of Experimental Medicine 209 (5), 889-893, 2012 | 216 | 2012 |
Misregulated RNA processing in amyotrophic lateral sclerosis M Polymenidou, C Lagier-Tourenne, KR Hutt, CF Bennett, DW Cleveland, ... Brain research 1462, 3-15, 2012 | 212 | 2012 |
Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8 J Kranich, NJ Krautler, E Heinen, M Polymenidou, C Bridel, ... The Journal of experimental medicine 205 (6), 1293-1302, 2008 | 205 | 2008 |
The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes M Polymenidou, R Moos, M Scott, C Sigurdson, Y Shi, B Yajima, ... PloS one 3 (12), e3872, 2008 | 201 | 2008 |